New research from the University of Colorado Anschutz Medical Campus studies a new tool that will help medical providers identify patients who are failing epilepsy treatments earlier in order to change treatment to rapidly optimize positive outcomes.
It was only his first visit to a hospital’s ALS clinic, but already the Black patient’s amyotrophic lateral sclerosis (ALS) had progressed beyond a point for an effective intervention. This memory sticks with Zach Cox, […]
Visitors from a local high school held real human brains, virtually dissected a body donated to science and gazed at a 10-foot rendition of optic neurons during a recent anatomy lesson with an artistic twist […]
Think Bioscience welcomes new investor YK Bioventures and drug discovery veteran Wendy Young to the board BOULDER, Colo., May 7, 2024 /PRNewswire/ — Think Bioscience (“Think”), a Boulder-based synthetic biology company focused on developing small-molecule […]
Copyright © 2026 Biotech Networks
